Despite all of the focus on preventing suicides in those who have served in the military, a significant proportion of veterans with suicidal ideation do not take advantage of available mental health treatment, according to a new study.
VA Takes Multi-track Approach for Veterans with Serious Mental Illness
WASHINGTON—The COVID-19 pandemic closed many hospitals and clinics across the U.S. this spring, but that didn’t stop the VA from supporting veterans with serious mental illness. To the contrary, it led to an expansion of service approaches that may prove valuable even...
VA Prepares for Increased Risk of Suicide With COVID-19 Isolation
WASHINGTON — As the COVID-19 pandemic continues and scientists predict more periods of social distancing and quarantine in the future, healthcare leaders in the VA and elsewhere are beginning to prepare for how this will impact the mental health of veterans and civilians alike.
VA Mental Healthcare Being Used by Depressed, Pregnant Vets
WORCESTER, MA—While depression screening is recommended for all pregnant veterans, it had remained unknown how often symptomatic women received care, how depression treatment presented in practice, and whether women veterans were utilizing treatment during the...
Communication, Organizational Gaps Contribute to Suicides at VAMCs
WASHINGTON—While the VA has declared preventing veteran suicide to be their top priority, veterans continue to attempt or commit suicide at VA healthcare facilities. Recent reports from the VA Inspector General’s Office suggest that the deficiencies that allow these...
Ensuring Community Providers Meet Veteran Suicide Prevention Standards
WASHINGTON — As leaders from across multiple federal agencies begin work on a roadmap to combat veteran suicide, they are searching for ways to turn existing efforts in towns, cities, counties and neighborhoods across the country into a net that can help catch struggling veterans.
Debate Continues on Esketamine Efficacy and Safety for Depression Treatment
PHILADELPHIA—Is esketamine a revolutionary treatment for depression or just another moderately effective adjunctive medication with some potentially serious risks? The VA’s Medical Advisory Panel leaned toward the latter position when it decided in June to approve the use of esketamine on a nonformulary basis for individuals who have previously failed at least two trials of other antidepressants.
VA Now Allows New Therapy Option for Treatment-Resistant Depression
Condition Significantly Increases Veterans’ Healthcare Costs ORLANDO, FL—VA clinicians now will be able to prescribe a form of ketamine to help patients with treatment-resistant depression. The condition is associated with healthcare resource utilization and costs at...
VA Study Addresses Concerns About Anti-Epileptic Drugs, Suicidal Behavior Link
In 2008, the U.S. Food and Drug Administration issued an alert about increased risk for suicidal ideation and behavior for patients taking anti-epileptic drugs (AEDs).